Looking at it as a new pick now; would I buy Medif today?
Even if they shipped double Q3 doesn't mean they got paid for it as we learned here before.
If doubled, and assuming everybody pays them, then last Q they made $4.9M, so I suppose they want us to assume $9.8M. We have no idea the costs that offset that.
That number included global operations.
Any growth is positive though, and peeps don't care about valuation much these days and with reasonable $80M market cap.
Usually I need to have confidence in management so I left with the CEO here. Clearly there are unknown problems at C-suite level. Worse Pat remains as Chairman of the BOD to run that while for whatever reasons he was unable to run the company itself as CEO.
There hasn't been a CFO since the end of November so where is this accounting coming from? Now I have to continue to worry about the accuracy of that and again, if there is a problem why Kwon left we don't know about.
Peeps here shouldn't think they are immune from a new CEO that first thing they do is dilute because he's got big plans so the shareholders are supposed to be excited about being dumped on.
I once thought MEDIF was going to be a legalization market leader, as most of us did, even picked over Valens ouch, then the vape scare etc, but sadly it's just a penny stock today and should be treated as such until proven otherwise.
glta
News 
Market Data 
Discover 
